Article Text

Download PDFPDF
Choroidal metastasis from gastrointestinal stromal tumour: a case report
  1. C M Gentile1,
  2. A A Lombardi2,
  3. J O Croxatto3
  1. 1
    Ocular Oncology, Hospital Italiano, Buenos Aires, Argentina
  2. 2
    Clinical and Surgical Retina, Hospital Italiano, Buenos Aires, Argentina
  3. 3
    Ocular Oncology, Hospital Italiano, Buenos Aires, Argentina
  1. C Gentile, Ocular Oncology Unit, Department of Ophthalmology, Hospital Italiano Buenos Aires, Gascón 450, Ciudad de Buenos Aires 1181, Argentina; carolina.gentile{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Metastatic disease is the most frequent intraocular malignancy in adults. The most common sites of origin are breast and lung. The vast majority of metastatic intraocular tumours are carcinomas, and rarely neuroendocrine tumours and sarcomas. Gastrointestinal stromal tumours (GIST) constitute a distinct group of gastrointestinal tumours arising from the interstitial cells of Cajal, regulators of peristalsis. The development of imatinib mesylate, a receptor tyrosine kinase inhibitor, has made a major impact on the management of advanced GISTs. We report the case of a patient with choroidal and systemic disease from a GIST, who underwent therapy with imatinib. An accurate diagnosis is required since therapy may differ from the most common metastatic carcinomas.

Case report

A …

View Full Text


  • Competing interests: The authors have no commercial interest regarding procedures, techniques and drugs mentioned in this manuscript.